The federal agency responsible for policing fraud in the U.S. healthcare system recovered $5.56 billion in expected financial recoveries and savings during six months, while banning more than 1,200 providers, companies, and individuals from participating in Medicare, Medicaid, and other federal health programs, according to a semiannual report to Congress released by the Department of Health and Human Services Office of Inspector General in July 2026.
The report covers the period from October 2025 through March 2026. The OIG said it returned $12.70 for every dollar it spent on fraud enforcement during the period, a return-on-investment figure the agency described as a demonstration of the fiscal value of healthcare fraud detection. Inspector General T. March Bell stated in the report that the OIG "is determined to hold bad actors accountable."
Why This Matters
Healthcare fraud is not a victimless crime. The OIG's own guidelines make clear that fraud diverts taxpayer-funded healthcare dollars away from legitimate medical services, but the harm extends further. Officials warn that fraud can expose patients to unnecessary medical procedures ordered for billing purposes, fraudulent prescriptions with no clinical basis, delayed access to legitimate care, and identity theft when personal health information is compromised as part of billing schemes.
Medicare and Medicaid collectively cover more than 150 million Americans. When fraudulent billing inflates costs or crowds out legitimate reimbursement, the consequences ripple through program budgets that affect real patients' coverage. The OIG's exclusion list, which bars individuals and entities from participating in federal healthcare programs, serves as a direct patient protection tool: providers on the exclusion list cannot legally bill Medicare or Medicaid for services, and patients who are seen by an excluded provider may lose coverage for those services.
What We Know So Far
The $5.56 billion figure represents expected recoveries and projected savings, a standard accounting framework the OIG uses that includes criminal fines, civil settlements, and administrative recoveries. Two headline cases illustrate the scope of fraud addressed during the period.
A telemedicine software executive received a 15-year prison sentence in connection with a $1 billion fraudulent billing scheme. Separately, Kaiser Permanente affiliates and CVS Health's Aetna reached combined settlements totaling $674 million over allegations of inflated billing in Medicare Advantage plans, which cover approximately half of all Medicare beneficiaries.
The 1,212 exclusions from federal programs during the six months continue what the OIG itself describes as a downward trend: approximately 1,500 exclusions were recorded in the same period in 2025 and approximately 1,800 in spring 2024. That declining trend reflects reduced staffing and enforcement capacity at the agency, even as the financial recoveries remain substantial due to large individual settlements.
Where the Risk Is Highest
Healthcare fraud is not evenly distributed. Investigations and prosecutions have historically concentrated in states with large Medicare and Medicaid populations, including Florida, Texas, California, New York, and Michigan. The Miami, Houston, Dallas, Los Angeles, and New York metro areas have each been sites of major federal healthcare fraud operations in recent years. Home health billing fraud, durable medical equipment schemes, telemedicine billing fraud, and Medicare Advantage inflated risk scores are the most persistently prosecuted categories.
The OIG maintains a publicly searchable exclusion database that patients, employers, and healthcare administrators can use to check whether a provider or entity has been banned from federal programs. Patients with Medicare or Medicaid coverage who are concerned about the credentials of a provider they see can search the database by name.
What Doctors and Experts Say
The OIG report's release came amid broader friction between the watchdog and the current administration. While the OIG is collaborating with a White House fraud task force led by Vice President JD Vance, the agency's enforcement data tell a more complicated story than the administration's fraud rhetoric suggests. Reuters reported that combined criminal and civil actions during the reporting period dropped to 604, down from 833 in the prior six-month period and the lowest in at least two years, despite the recovery total appearing strong because of a few very large settlements.
Healthcare policy analysts note that the return-on-investment figure of $12.70 per dollar spent has been used by both Republican and Democratic administrations to justify OIG funding. The agency's statutory independence from political direction is central to its credibility as a watchdog, and the tension between that independence and the current administration's parallel fraud-fighting initiatives has been noted in reporting from multiple outlets.
What the Evidence Shows and What It Does Not
The $5.56 billion figure encompasses expected recoveries and savings, not all of which have been fully collected. Civil settlements and administrative recoveries take time to be paid, and some amounts may be reduced through appeals or bankruptcy proceedings. The OIG's metric is standard for the agency and allows consistent year-over-year comparison, but patients and policymakers should understand it includes both completed recoveries and projected future savings. The 1,212 exclusions represent actions taken based on completed investigations. The declining exclusion count does not necessarily mean fraud is declining; it reflects enforcement capacity and case prioritization. The OIG specifically noted that the drop in exclusions continues a two-year downward trend.
Who Faces the Greatest Risk
Medicare beneficiaries, who are most commonly targeted by fraudulent billing schemes, face the highest exposure. Older adults are disproportionately represented in Medicare and are more likely to be harmed by unnecessary procedures ordered for billing purposes or by identity theft through compromised medical records. Medicaid beneficiaries, who often lack the resources to independently monitor their billing records, are similarly vulnerable. Healthcare workers who suspect they are being asked to participate in fraudulent billing practices face their own risks: reporting fraud through the OIG's whistleblower program carries legal protections.
Symptoms and Warning Signs to Watch For
Patients can identify potential fraud by reviewing their Medicare or Medicaid Summary Notices for services they did not receive, providers they did not visit, duplicate billing for the same service, or equipment charges they never received. Any unexplained medical claim, bill from an unknown provider, or request for a Medicare or Medicaid number outside of a clinical encounter should be treated as a potential red flag. The OIG's fraud hotline is available at 1-800-HHS-TIPS.
What You Can Do Now
Patients on Medicare can review their claims online through their Medicare account at Medicare.gov and can sign up for Medicare Summary Notices that detail billing on their behalf. Anyone who suspects fraudulent billing should report it to the OIG hotline at 1-800-HHS-TIPS or online at oig.hhs.gov. Before agreeing to any procedure, patients can ask their provider why it is medically necessary and request documentation of the clinical reason. Checking whether a provider appears on the OIG exclusion list before seeking care is a straightforward protective step for Medicare and Medicaid beneficiaries.
Cost and Access: What Patients Should Know
Services provided by excluded providers cannot be billed to Medicare or Medicaid, meaning patients who receive care from an excluded provider may be held personally responsible for the cost. Patients who are billed for services they did not receive should dispute those bills through their insurer or through Medicare's formal dispute process. Medicare beneficiaries facing billing concerns can contact their State Health Insurance Assistance Program, or SHIP, for free counseling through a federally funded network of advisors available in every state.
What Happens Next
The OIG's next semiannual report, covering April through September 2026, will be the clearest measure of how enforcement activity trends as the fraud task force collaboration develops. The agency is also expected to release updated guidance on telemedicine billing, which has been a persistent fraud vector since the COVID-19 pandemic expanded telehealth coverage. MedicalDaily will report on significant enforcement actions and policy updates affecting Medicare and Medicaid beneficiaries as they occur.
The Bottom Line
The HHS OIG's latest report shows a federal watchdog agency that is financially productive, recovering $12.70 for every dollar spent, but one whose enforcement actions are declining even as large settlements inflate the total recovery figure. For patients, the most important takeaway is practical: review your Medicare and Medicaid billing statements regularly, check providers against the exclusion list, and report suspicious billing through the OIG's hotline. Healthcare fraud diverts resources from legitimate care, and patient reporting is one of the most effective detection tools available.
